Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03355976
Title BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Don Dizon
Indications

fallopian tube clear cell adenocarcinoma

ovarian clear cell carcinoma

renal pelvis carcinoma

peritoneal carcinoma

Therapies

Ipilimumab + Nivolumab

Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.